Unknown

Dataset Information

0

Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-signaling pathway.


ABSTRACT: Multidrug resistance-associated protein 3 (MRP3, ABC subfamily C [ABCC]3) plays an important role in protecting hepatocytes and other tissues by excreting an array of toxic organic anion conjugates, including bile salts. MRP3/ABCC3 expression is increased in the liver of some cholestatic patients, but the molecular mechanism of this up-regulation remains elusive. In this report, we assessed liver MRP3/ABCC3 expression in patients (n = 22) with obstructive cholestasis caused by gallstone blockage of bile ducts and noncholestatic patient controls (n = 22). MRP3/ABCC3 messenger RNA (mRNA) and protein expression were significantly increased by 3.4- and 4.6-fold, respectively, in these cholestatic patients where elevated plasma tumor necrosis factor alpha (TNF?) (4.7-fold; P < 0.01) and hepatic specificity protein 1 transcription factor (SP1) and liver receptor homolog 1 expression (3.1- and 2.1-fold at mRNA level, 3.5- and 2.5-fold at protein level, respectively) were also observed. The induction of hepatic MRP3/ABCC3 mRNA expression is significantly positively correlated with the level of plasma TNF? in these patients. In HepG2 cells, TNF? treatment induced SP1 and MRP3/ABCC3 expression in a dose- and time-dependent manner, where increased phosphorylation of c-Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) was also detected. These inductions were significantly reduced in the presence of the JNK inhibitor, SP600125. TNF? treatment enhanced HepG2 cell nuclear extract-binding activity to the MRP3/ABCC3 promoter, but was abolished by SP600125, as demonstrated by electrophoretic mobility shift assay (EMSA). An increase in nuclear protein-binding activity to the MRP3/ABCC3 promoter, consisting primarily of SP1, was also observed in liver samples from cholestatic patients, as assessed by supershift EMSA assays.Our findings indicate that up-regulation of hepatic MRP3/ABCC3 expression in human obstructive cholestasis is likely triggered by TNF?, mediated by activation of JNK/SAPK and SP1.

SUBMITTER: Chai J 

PROVIDER: S-EPMC3297707 | biostudies-literature | 2012 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-signaling pathway.

Chai Jin J   He Yu Y   Cai Shi-Ying SY   Jiang Zhongyong Z   Wang Huaizhi H   Li Qiong Q   Chen Lei L   Peng Zhihong Z   He Xiaochong X   Wu Xiaoping X   Xiao Tianli T   Wang Rongquan R   Boyer James L JL   Chen Wensheng W  

Hepatology (Baltimore, Md.) 20120501 5


<h4>Unlabelled</h4>Multidrug resistance-associated protein 3 (MRP3, ABC subfamily C [ABCC]3) plays an important role in protecting hepatocytes and other tissues by excreting an array of toxic organic anion conjugates, including bile salts. MRP3/ABCC3 expression is increased in the liver of some cholestatic patients, but the molecular mechanism of this up-regulation remains elusive. In this report, we assessed liver MRP3/ABCC3 expression in patients (n = 22) with obstructive cholestasis caused by  ...[more]

Similar Datasets

| S-EPMC4027943 | biostudies-literature
| S-EPMC2239246 | biostudies-literature
| S-EPMC23822 | biostudies-literature
| S-EPMC4694892 | biostudies-literature
| S-EPMC4086246 | biostudies-literature
| S-EPMC4049334 | biostudies-literature
| S-EPMC4344457 | biostudies-literature
| S-EPMC6724916 | biostudies-literature
| S-EPMC1182319 | biostudies-literature
| S-EPMC7362505 | biostudies-literature